Entries |
Document | Title | Date |
20080215104 | Apparatus and method for temporary treatment of acute heart failure decompensation - A system for providing temporary therapy, such as cardiac resynchronization therapy, to a patient suffering a decompensation event. The system can include a device having an external module for generating electrical stimuli, a first lead coupled to the module and implanted into an atrial region of a patient's heart, and a second lead coupled to the module and implanted into a ventricular region of the patient's heart. The device can also include a storage module coupled to the external module to store data associated with physiological data measured by the device. The external module is configured to temporarily generate electrical stimuli that are delivered by at least one of the first and second leads to provide therapy cardiac resynchronization therapy to the heart. A network can be coupled to the device to allow data stored in the device to be downloaded through the network to a central repository. | 09-04-2008 |
20080228235 | Device and method for fixing an electrical lead - An electrical lead for a cardiac pacing device includes a body including a tip portion defining a void. A fixation device is coupled to the body. The fixation device is at least partially positioned within the void in a compressed configuration and movable between the compressed configuration and a deployed configuration to facilitate fixing the electrical lead within the vessel. | 09-18-2008 |
20080269815 | Method and Apparatus for Providing Extra Systolic Stimulation - An implantable medical device and associated method control the delivery of extra systolic stimulation by determining a coupling interval, setting an extra systolic interval in response to the coupling interval; and delivering a supraventricular stimulation pulse upon expiration of the extra systolic interval. The supraventricular stimulation pulse evokes a depolarization that is conducted to the ventricles occurring at a ventricular coupling interval relative to a ventricular event. | 10-30-2008 |
20080269816 | Method and Apparatus to Deliver Mechanically Fused Pacing Therapy - A medical device system and method for delivering mechanically fused left ventricular cardiac stimulation. A sensor monitors left ventricular acceleration while left ventricular cardiac stimulation is provided at an AV interval. The left ventricular acceleration is used to calculate a mechanical response interval and the mechanical response interval is compared to a desired mechanical response interval. The AV interval is adjusted until the mechanical response interval is equal to the desired mechanical response interval. | 10-30-2008 |
20080269817 | IMPLANTABLE MEDICAL DEVICE FOR BIVENTRICULAR STIMULATION - A heart stimulator for biventricular pacing comprises at least one stimulation pulse generator connected or connectable to a right ventricular or atrial stimulation electrode lead and a left ventricular or atrial electrode lead, respectively. The heart stimulator is adapted to generate right chamber stimulation pulses for a right atrium or ventricle and left chamber stimulation pulses for a left ventricle or atrium. A high rate protection unit connected to said stimulation pulse generator is adapted to trigger, upon any right or left chamber stimulation pulse, a protection time window having a predetermined duration in time and comprising an early part immediately followed by a late part. The protection unit is further adapted to only allow atrial or ventricular stimulation pulses in said early part of said protection time window and to suppress any atrial or ventricular stimulation pulse in said late part. | 10-30-2008 |
20080275516 | METHOD AND APPARATUS FOR DETECTING ARRHYTHMIAS IN A MEDICAL DEVICE - A method and apparatus of updating a sensing parameter in a medical device that includes sensing cardiac signals, determining intervals in response to the sensed cardiac signals, determining interval patterns associated with the determined intervals, and updating the sensing parameter in response to the determined interval patterns. | 11-06-2008 |
20080275517 | METHOD AND APPARATUS FOR DETECTING ARRHYTHMIAS IN A MEDICAL DEVICE - A method and apparatus for determining oversensing in a medical device that includes sensing cardiac signals, determining an oversensing characteristic associated with cardiac signals sensed during a predetermined sensing window, identifying oversensing in response to the oversensing characteristic, determining, in response to oversensing being identified, an adjusting characteristic associated with cardiac signals sensed during the predetermined sensing window, and updating a sensing parameter in response to the determined adjusting characteristic. | 11-06-2008 |
20080281369 | System And Method For Determining The Origin Of A Sensed Beat - A method for monitoring a biological cardiac pacemaker is provided. The method may include stimulating a heart at a region selected for implantation of a biological pacemaker and sensing at least one electrical signal indicative of a cardiac depolarization originating in the region selected for implantation of the biological pacemaker. The method may further include sensing at least one subsequent electrical signal produced by the heart and determining if the subsequent electrical signal originated in the region selected for the biological pacemaker or another region of the heart. In an alternative embodiment, the method may include determining a template time difference between two points on cardiac complexes sensed in two or more different cardiac locations during normal sinus rhythm. The method may further include determining a time difference between two points on a subsequent cardiac complex sensed in two or more different cardiac locations. The time differences may be compared to determine if the subsequently-sensed cardiac complex originates in a left ventricular biological pacemaker site or in another cardiac site. | 11-13-2008 |
20080288012 | SYSTEM AND METHOD FOR CARDIAC RHYTHM MANAGEMENT WITH SYNCHRONIZED PACING PROTECTION PERIOD - A device and method for cardiac rhythm management in which a heart chamber is paced in accordance with a pacing mode that employs sense signals from the opposite chamber. A protection period triggered by the sensing of intrinsic activity in the paced chamber is used to inhibit pacing without otherwise disturbing the pacing algorithm. | 11-20-2008 |
20080294211 | COUPLED MONOPOLAR AND MULTIPOLAR PULSING FOR CONDITIONING AND STIMULATION - A method and neurostimulation system of providing therapy to a patient is provided. A plurality of electrodes are placed in contact with tissue of a patient, a conditioning pulse is conveyed from the plurality of electrodes in one of a monopolar manner and a multipolar manner, and a stimulation pulse is conveyed from the plurality of electrodes in a different one of the monopolar manner and the multipolar manner. As one example, the sub-threshold conditioning pulse may be a depolarizing pulse conveyed from the plurality of electrodes to render a first region of the tissue less excitable to stimulation, and the stimulation pulse may be conveyed from the plurality of electrodes to stimulate a second different region of the tissue. | 11-27-2008 |
20080319497 | Architectures for an Implantable Medical Device System - An improved architecture for an implantable medical device such as an implantable pulse generator (IPG) is disclosed. In one embodiment, the various functional blocks for the IPG are incorporated into a signal integrated circuit (IC). Each of the functional blocks communicate with each other, and with other off-chip devices if necessary, via a centralized bus governed by a communication protocol. To communicate with the bus and to adhere to the protocol, each circuit block includes bus interface circuitry adherent with that protocol. Because each block complies with the protocol, any given block can easily be modified or upgraded without affecting the design of the other blocks, facilitating debugging and upgrading of the IPG circuitry. Moreover, because the centralized bus can be taken off the integrated circuit, extra circuitry can easily be added off chip to modify or add functionality to the IPG without the need for a major redesign of the main IPG IC. | 12-25-2008 |
20090043347 | Method and system for characterizing supraventricular rhythm during cardiac pacing - A method and system for generating a characterization of one beat of a patient's supraventricular rhythm (SVR) involves performing such characterization while the heart is being paced. During SVR characterization, various pacing parameters are modified and the patient's supraventricular rhythm is characterized while the pacing parameters are modified. The SVR characterization process is effective in single and multiple chamber pacing modes. | 02-12-2009 |
20090048637 | CLOSED LOOP IMPEDANCE-BASED CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS, DEVICES, AND METHODS - This document discusses, among other things, systems, devices, and methods measure an impedance and, in response, adjust an atrioventricular (AV) delay or other cardiac resynchronization therapy (CRT) parameter that synchronizes left and right ventricular contractions. A first example uses parameterizes a first ventricular volume against a second ventricular volume during a cardiac cycle, using a loop area to create a synchronization fraction (SF). The CRT parameter is adjusted in closed-loop fashion to increase the SF. A second example measures a septal-freewall phase difference (PD), and adjusts a CRT parameter to decrease the PD. A third example measures a peak-to-peak volume or maximum rate of change in ventricular volume, and adjusts a CRT parameter to increase the peak-to-peak volume or maximum rate of change in the ventricular volume. | 02-19-2009 |
20090054941 | STIMULATION FIELD MANAGEMENT - This disclosure describes techniques for controlling a depth of propagation of a stimulation field extending from an outer diameter of a lead body of an implantable stimulation lead. An implantable electrical stimulation lead may include a lead body, and at least one electrode arranged as a ring. An outer diameter of the ring may be different than an outer diameter of the lead body. A ring with a diameter smaller than the diameter of the lead body may be useful in limiting the depth of propagation of the stimulation field within patient tissue. A ring with a diameter greater than the diameter of the lead body may be useful in extending the depth of propagation of the stimulation field. | 02-26-2009 |
20090062876 | Quantum dot labeled stem cells for use in providing pacemaker function - The present invention provides methods and compositions relating to the labeling of target cells with nanometer scale fluorescent semiconductors referred to as quantum dots (QDs). Specifically, a delivery system is disclosed based on the use of negatively charged QDs for delivery of a tracking fluorescent signal into the cytosol of target cells via a passive endocytosis-mediated delivery process. In a specific embodiment of the invention the target cell is a stem cell, preferably a mesenchymal stem cell (MSC). Such labeled MSCs provide a means for tracking the distribution and fate of MSCs that have been genetically engineered to express, for example, a hyperpolarization-activated cyclic nucleotide-gated (“HCN”) channel and administered to a subject to create a biological pacemaker. The invention is based on the discovery that MSCs can be tracked in vitro for up to at least 6 weeks. Additionally, QDs delivered in vivo can be tracked for up to at least 8 weeks, thereby permitting for the first time, the complete 3-D reconstruction of the locations of all MSCs following administration into a host. | 03-05-2009 |
20090088811 | IMPLANTABLE LEAD WITH AN ELECTROSTIMULATION CAPACITOR - One example includes an implantable lead with an elongate lead body including a proximal portion and a distal portion. The lead includes a coupler configured to be coupled to an implantable medical device, a conductor, extending through the coupler, a first electrode, and a first electrostimulation capacitor located at the distal portion of the lead body, the first electrostimulation capacitor including a capacitance value that is large enough to store an electrostimulation charge of an electrostimulation energy that is large enough to perform electrostimulation of tissue. The lead includes a first switch located at the distal portion of the lead body and coupled to the conductor, the first switch configured to selectively couple the first electrostimulation capacitor to the first electrode during a stimulating state and to selectively couple the first electrostimulation capacitor to the conductor during a charging state. | 04-02-2009 |
20090088812 | IMPLANTABLE LEAD WITH ELECTRONICS - One example includes an implantable lead including an elongate lead body which includes a proximal portion and a distal portion. In the example, the lead includes a coupler configured to couple to an implantable medical device. The lead includes a first conductor, coupled to the coupler, and extending away from the coupler at least partially through the lead. The lead includes a first electrode, located on the lead away from the coupler and a first switch, located on the lead away from the coupler, the first switch configured to control conductivity between the conductor and the electrode. The lead also includes a first controller circuit, coupled to the conductor and including a first multiplexer circuit configured to multiplex over the conductor a first signal and a second signal, the first controller circuit configured to control the first switch based at least on the first signal. | 04-02-2009 |
20090118781 | THERAPY-SELECTION METHODS FOR IMPLANTABLE HEART MONITORS - An implantable heart-monitoring device comprising one or more leads for sensing electrical signals of a patient's heart a therapy circuit for delivering pharmaceuticals to the patient; and a monitoring circuit coupled to the one or more leads and to the therapy circuit, the monitoring circuit for monitoring heart activity of the patient through one or more of the leads, the monitoring circuit operable to: determine a minimum interval from a set of two or more intervals based on sensed heart activity, determine a range parameter based on a difference between a first subset and second subset of the intervals, determine a dispersion parameter quantifying dispersion of a subset of the intervals, and to determine an assessment value for the set of intervals, based on the minimum interval, the range parameter, the dispersion index. | 05-07-2009 |
20090149905 | CONFIGURATION OF PACING OUTPUT CHANNELS - During auto-threshold, autocapture, or other evoked response sensing, post-pace artifact is reduced by using a smaller coupling capacitor value than what is used when not in such an evoked response sensing configuration. This can be accomplished by borrowing another capacitor for use as the coupling capacitor. The borrowed capacitor can be a backup pacing capacitor from the same or a different pacing channel. The borrowed capacitor can also be a coupling capacitor from a different pacing channel. | 06-11-2009 |
20090149906 | METHOD AND APPARATUS FOR DISCONNECTING THE TIP ELECTRODE DURING MRI - A medical device includes a pulse generator, a lead, and an electrode. The lead includes an electrode and a lead conductor connecting the pulse generator with the electrode via first and second conductive paths. The medical device includes first and second switches. The first switch includes a non-conductive state in the presence of a magnetic field, the non-conductive state preventing formation of the first conductive path between the pulse generator and the electrode. The second switch includes a non-conductive state that prevents formation of the second conductive path between the pulse generator and the electrode. The first switch in the non-conductive state and the second switch in the non-conductive state electrically shields the electrode from electromagnetic radiation and induced voltages during a magnetic resonance imaging procedure. | 06-11-2009 |
20090157133 | SUPRAVENTRICULAR TACHY SENSING VECTOR - A system includes a pulse generator including a can electrode and a lead couplable to the pulse generator, the lead including a distal coil electrode and a proximal coil electrode, wherein both of the coil electrodes are electrically uncoupled from the can electrode such that a unipolar sensing vector is provided between at least one of the coil electrodes and the can electrode. | 06-18-2009 |
20090157134 | Device For Characterizing the Cardiac Status Of A Patient Equipped With A Biventricular Pacing Active Implant - A medical device for characterizing the cardiac status of a patient equipped with a bi-ventricular pacing active implant device. The implant collects an endocardiac acceleration signal and searches for an optimal pacing configuration. This latter tests a plurality of different pacing configurations and delivers for each tested configuration parameters derived from the endocardiac acceleration peak (PEA). The device derives a patient clinical status from those parameters, the indication being representative of the patient's response to the cardiac resynchronization therapy. Those parameters include: the possibility to automatically get or not a valid optimal AV Delay among all the biventricular pacing configurations; a factor indicating the character sigmoid of the PEA/AVD characteristic; the average value of the PEA for the various configurations; and the PEA signal/noise ratio. The active implantable medical device includes control software and processes for executing the characterizing functionality described. | 06-18-2009 |
20090171410 | IMPLANTABLE PULSE GENERATOR PROGRAMMING VIA ELECTRODES - Apparatus is provided, including a control unit configured for implantation in a body of a subject. An electrode is coupled to the control unit. The control unit is configured to receive programming instructions via the electrode and to drive current into tissue of the subject via the electrode. Other embodiments are also described. | 07-02-2009 |
20090187226 | VENTRICULAR PACING - A method and apparatus are disclosed for treating a condition of a patient's heart includes placing a first electrode and/or a second electrode in a right ventricle of the heart. In one example, a reference electrode is placed within the patient and internal or external to the heart. A pacing signal is generated including a first signal component, a second signal component and a reference component with the first and second signal components having opposite polarity and with both of the first and second components having a potential relative to the reference component. The pacing signal and the placement of the electrodes are selected to alter a contraction of a left ventricle of the heart. | 07-23-2009 |
20090234404 | Methods and devices for modulation of heart valve function - Methods and devices for modulating heart valve function are provided. In the subject methods, a heart valve is first in structurally modified. Blood flow through the structurally modified heart valve is then monitored, and the heart is paced in response to the monitored blood flow. Also provided are devices, systems and kits that find use in practicing the subject methods. The subject methods find use in a variety of applications. | 09-17-2009 |
20090240298 | SWITCH POLARITY PACING TO IMPROVE CARDIAC RESYNCHRONIZATION THERAPY - The invention is directed to a heart stimulator for left-ventricular pacing comprising a left ventricular stimulation pulse generator connected or connectable to a single electrode lead for left ventricular stimulation having one or more electrodes for delivery of stimulation pulses to left ventricular myocardial heart tissue, said stimulation pulse generator being adapted to generate and deliver stimulation pulses of switchable polarity. The heart stimulator further comprises a control unit connected to the stimulation pulse generator for controlling the stimulation pulse generator and to trigger generation and delivery of stimulation pulses having a polarity controlled by said control unit, wherein the control unit is adapted to control said left ventricular stimulation pulse generator so as to deliver at least a pair of suprathreshold stimulation pulses of opposite polarity. | 09-24-2009 |
20090281587 | SYSTEM AND METHOD FOR DETECTING HIDDEN ATRIAL EVENTS FOR USE WITH AUTOMATIC MODE SWITCHING WITHIN AN IMPLANTABLE MEDICAL DEVICE - Techniques are provided for detecting atrial events that might be hidden due to the operation of a post-ventricular atrial blanking (PVAB) interval or other atrial channel blanking interval. In one example, candidate atrial events are identified within signals occurring during the PVAB interval. Then, a determination is made as to whether the candidate atrial event is a true atrial event based on a comparison of characteristics of the candidate atrial event with characteristics of prior known atrial events within the patient. By comparing the characteristics of the “hidden” event with the characteristics of prior known atrial events within the patient, a quick and accurate determination can be made whether the event should be counted as a P-wave. In this manner, hidden atrial arrhythmias can be detected and mode switch oscillations can be reduced or eliminated. | 11-12-2009 |
20090287267 | System and Method for Estimating Cardiac Pressure Based on Cardiac Electrical Conduction Delays Using an Implantable Medical Device - Techniques are provided for estimating left atrial pressure (LAP) or other cardiac performance parameters based on measured conduction delays. In particular, LAP is estimated based interventricular conduction delays. Predetermined conversion factors stored within the device are used to convert the various the conduction delays into LAP values or other appropriate cardiac performance parameters. The conversion factors may be, for example, slope and baseline values derived during an initial calibration procedure performed by an external system, such as an external programmer. In some examples, the slope and baseline values may be periodically re-calibrated by the implantable device itself. Techniques are also described for adaptively adjusting pacing parameters based on estimated LAP or other cardiac performance parameters. Still further, techniques are described for estimating conduction delays based on impedance or admittance values and for tracking heart failure therefrom. | 11-19-2009 |
20090292333 | ELECTRICAL STIMULATION TREATMENT OF HYPOTENSION - Methods and devices for treating hypotension, such as in cases of shock, including septic shock and anaphylactic shock, wherein the treatment includes providing an electrical impulse to a selected region of the vagus nerve of a patient suffering from hypotension to block and/or modulate nerve signals that regulate blood pressure. | 11-26-2009 |
20090299423 | SYSTEMS AND METHODS FOR DETERMINING INTER-ATRIAL CONDUCTION DELAYS USING MULTI-POLE LEFT VENTRICULAR PACING/SENSING LEADS - Techniques are provided for use by a pacemaker or other implantable medical device for estimating optimal atrio-ventricular pacing delays within a patient. The inter-atrial conduction delays (IACDs) are determined based, at least in part, on atrial far-field (AFF) signals sensed using a multi-pole left ventricular (LV) lead, such as an LV lead implanted via the coronary sinus (CS) with a plurality of electrodes. In one example, for intrinsic atrial events, the IACD is equal to the interval from the beginning of a P-wave detected via a right atrial lead and the end (or peak) of an AFF event detected via a left atrial ring electrode of a CS/LV lead. For paced atrial events, the IACD is instead equal to the interval from the A-pulse to the end (or peak) of the AFF event detected via the CS/LV lead. AV/PV pacing delays are then calculated based on the IACD adjusted by an offset. | 12-03-2009 |
20090299424 | Methods and systems for treating heart instability - Systems and methods define an index of risk for cardiac disease by detecting cellular derangements that may lead to cardiomyopathy, heart rhythm disorders or ischemic heart disease. The markers include fluctuations or abnormal rate-behavior of electrical, mechanical or other measurable biosignals. The invention operates in modes that can be applied to prevent atrial fibrillation or the risk for ventricular arrhythmias. Alternative embodiments are applied to tissue outside the heart such as skeletal muscle, smooth muscle, the central nervous system, the respiratory system, the urogenital system and the gastrointestinal system. | 12-03-2009 |
20090306732 | CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION USING ELECTROMECHANICAL DELAY FROM REALTIME ELECTRODE MOTION TRACKING - An exemplary method includes providing a mechanical activation time (MA time) for a myocardial location, the location defined at least in part by an electrode and the mechanical activation time determined at least in part by movement of the electrode; providing an electrical activation time (EA time) for the myocardial location; and determining an electromechanical delay (EMD) for the myocardial location based on the difference between the mechanical activation time (MA time) and the electrical activation time (EA time). | 12-10-2009 |
20090318989 | PACING CATHETER WITH STENT ELECTRODE - Cardioprotective pacing is applied to prevent and/or reduce cardiac injury associated with myocardial infarction (MI) and revascularization procedure. Pacing pulses are generated from a pacemaker and delivered through one or more pacing electrodes incorporated onto one or more percutaneous transluminal vascular intervention (PTVI) devices during the revascularization procedure. In one embodiment, at least one pacing electrode is constructed as, or incorporated onto, a stent at a distal end portion of a stent catheter. | 12-24-2009 |
20100010553 | SYSTEM AND METHOD FOR FILTERING NEURAL STIMULATION - Various aspects of the present subject matter provide a filter module. In various embodiments, the filter module comprises an input, an output, a signal path from the input to the output, a filter and a switch. The filter has a transfer response to attenuate a frequency of a neural stimulation signal. The switch is adapted to place the filter in the signal path when the neural stimulation signal is applied and to remove the filter from the signal path when the neural stimulation signal is not applied. Other aspects are provided herein. | 01-14-2010 |
20100016911 | Local Lead To Improve Energy Efficiency In Implantable Wireless Acoustic Stimulators - A wireless cardiac stimulation device is disclosed comprising a controller-transmitter, a receiver, and a stimulating electrode, wherein the stimulating electrode and the receiver are separately implantable at cardiac tissue locations of the heart and are connected by a local lead. Having separately implantable receiver and stimulating electrodes improves the efficiency of ultrasound mediated wireless stimulation by allowing the receiver to be placed optimally for reception efficiency, thereby resulting in longer battery life, and by allowing the stimulating electrode to be placed optimally for stimulus delivery. Another advantage is a reduced risk of embolization, since the receiver and stimulating electrode ensemble is attached at two locations of the heart wall, with the connecting local leads serving as a safety tether should either the receiver or the stimulating electrode become dislodged. | 01-21-2010 |
20100023078 | Cardiac resynchronization therapy parameter optimization - Systems and methods involve determination of CRT parameters using a number of CRT optimization processes. Each CRT optimization process attempts to return recommended parameters. The CRT parameters are determined based on the recommended parameters returned by one or more of the CRT optimization processes. The CRT optimization processes may be sequentially implemented and the CRT parameters may be determined based on the recommended parameters returned by a first CRT optimization process to return recommended parameters. The CRT parameters may be determined based on a combination of the recommended parameters returned. The CRT optimization processes implemented may be selected from available CRT optimization processes based on patient conditions. | 01-28-2010 |
20100023079 | Cardiac Pacing Methods and Apparatus - A method and apparatus is provided for determining whether a current atrial-ventricular (AV) delay during cardiac pacing is appropriate for proper mechanical coupling of the atrium and ventricle. If proper mechanical coupling is determined to not exist, an additional atrial contraction is induced within the same ventricular cycle to maintain atrial-ventricular mechanical coupling. | 01-28-2010 |
20100049268 | MASTER/SLAVE PROCESSOR CONFIGURATION WITH FAULT RECOVERY - A fault-tolerant processor device including a master processor and a plurality of operationally coupled slave processors. The master processor sends a command to each of the slave processors to initiate operation to each control a different one of a plurality of operations during fault-free operation. The master processor monitors each of the operations to confirm the fault-free operation. In a case wherein fault-free operation is not confirmed, the master processor identifies a faulty one of the slave processors, disables the faulty slave processor and initiates operation of a fault-free one of the slave processors to control the operations of the faulty slave processor in addition to the operations of the fault-free slave processor. If the master processor determines that both of the slave processors are faulty, the master processor may disable both of the slave processors and control each of the operations independent of the faulty slave processors. | 02-25-2010 |
20100057154 | DEVICE AND METHOD FOR THE TRANSDERMAL STIMULATION OF A NERVE OF THE HUMAN BODY - The invention relates to a device for transdermal stimulation of a nerve of the human body, which device comprises at least one stimulation electrode and at least one reference electrode for transdermal nerve stimulation, the at least one stimulation electrode and the at least one reference electrode being connected to a control unit and being able to be supplied with an electrical current from the latter, and the at least one stimulation electrode and the at least one reference electrode being arranged in or on a housing which is designed to be fitted on or in the human ear. The invention further relates to a method for the transdermal stimulation of a nerve of the human body in particular of a part of the vagus nerve by applying an electrical stimulus via at least one stimulation electrode and at least one reference electrode, at least one of which is placed in contact with the skin surface of the inner face of the Tragus of the human ear. The invention further relates to transdermal stimulation of a part of the vagus nerve by electrical stimulation via the inner face of the Tragus of the human ear for the treatment and/or supportive therapy of a plurality of pathological conditions. | 03-04-2010 |
20100069982 | TIME BASED ARRHYTHMIA THERAPY EFFICACY CRITERIA - An implantable medical device and associated method classify therapy outcomes and heart rhythms in association with therapy outcome. A therapy success time interval is started in response to delivering an arrhythmia therapy. If normal sinus rhythm is detected after the therapy success time interval expires, the delivered therapy is classified as unsuccessful and the detected arrhythmia is classified as a self-terminating rhythm. | 03-18-2010 |
20100069983 | TRANSMUSCULAR LEFT VENTRICULAR CARDIAC STIMULATION LEADS AND RELATED SYSTEMS AND METHODS - A cardiac stimulation system and method delivers a left ventricle stimulator from a right ventricle lead system in the right ventricle chamber, into a right side of an interventricular septum at a first location, and transmuscularly from the first location to a second location along the left side of the septum. The left ventricle stimulator is affixed at the second location for transmuscular stimulation of the left ventricle conduction system. A biventricular stimulation system further includes a right ventricle stimulator also delivered by the right ventricle lead system to the first location along the right side of the septum for right ventricular stimulation. An energy source is coupled to the transmuscular stimulation system, i.e., a pacemaker, and/or defibrillator, or to enhance contractility, and may be coupled directly or via “leadless” system(s). Various highly beneficial particular arrangements of stimulators and leads are further described. | 03-18-2010 |
20100069984 | CARDIAC FUNCTION MANAGEMENT INTEGRATING CARDIAC CONTRACTILITY MODULATION - An implantable cardiac rhythm/function management system integrates cardiac contractility modulation (CCM) and one or more other therapies, such as to preserve device safety, improve efficacy, enhance sensing and detection, or enhance therapy effectiveness and delivery. Examples of the one or more other therapies can include pacing, defibrillation/cardioversion, cardiac resynchronization therapy (CRT), or neurostimulation. | 03-18-2010 |
20100069985 | CARDIAC FUNCTION MANAGEMENT INTEGRATING CARDIAC CONTRACTILITY MODULATION - An implantable cardiac rhythm/function management system integrates cardiac contractility modulation (CCM) and one or more other therapies, such as to preserve device safety, improve efficacy, enhance sensing and detection, or enhance therapy effectiveness and delivery. Examples of the one or more other therapies can include pacing, defibrillation/cardioversion, cardiac resynchronization therapy (CRT), or neurostimulation. | 03-18-2010 |
20100076511 | BAROREFLEX STIMULATION SYSTEM TO REDUCE HYPERTENSION - Various aspects of the present subject matter provide an implantable medical device. In various embodiments, the device comprises a pulse generator, a lead, a sensor, and a controller. The pulse generator generates a baroreflex stimulation signal as part of a baroreflex therapy. The lead is adapted to be electrically connected to the pulse generator and to be intravascularly fed into a heart. The lead includes an electrode to be positioned in or proximate to the heart to deliver the baroreflex signal to a baroreceptor region in or proximate to the heart. The sensor senses a physiological parameter regarding an efficacy of the baroreflex therapy and provides a signal indicative of the efficacy. The controller is connected to the pulse generator to control the baroreflex stimulation signal and to the sensor to receive the signal indicative of the efficacy of the baroreflex therapy. Other aspects are provided herein. | 03-25-2010 |
20100087885 | BIOSORBABLE BATTERY AND RELATED METHODS - Embodiments of the invention are related to biosorbable batteries, amongst other things. In an embodiment, the invention includes a biosorbable battery assembly including an anode, a cathode, and a biosorbable separation element. The anode can include an anode material, wherein electrochemical oxidation of the anode material results in the formation of reaction products that are substantially non-toxic. The cathode can include a cathode material, wherein electrochemical reduction of the cathode material results in the formation of reaction products that are substantially non-toxic, the cathode material having a larger standard reduction potential than the material of the anode. The biosorbable separation element can be disposed between the anode and the cathode and can be configured to provide electrical insulation between the anode and the cathode. In an embodiment, the invention includes a medical device system including an implanted medical device and a biosorbable battery in electrical communication with the implanted medical device. Other embodiments are also included herein. | 04-08-2010 |
20100114225 | HOUSING STRUCTURE FOR A MEDICAL IMPLANT INCLUDING A MONOLITHIC SUBSTRATE - Embodiments described herein provide lid structures for medical implant (MI) housing. In one embodiment, the invention provides a lid structure for a MI housing comprising a substrate comprising a dielectric material, a conductive portion fabricated on a substrate surface or interior, a frame at least partially surrounding the substrate perimeter, a plurality of vias projecting at least partially through the substrate, a plurality of conductive pins with at least one pin projecting through a via. The frame is hermetically joined to the substrate and can be hermetically joined to the housing. The conductive portion allows electrical components, including capacitors, inductors, resistor and antennas to be fabricated on or coupled to the substrate surface or interior. The antenna comprises a conductive trace positioned on a substrate top surface and is configured to send and receive signals between an implant within a patient's body and a communication device external to the body. | 05-06-2010 |
20100114226 | SYSTEM TO PROVIDE MYOCARDIAL AND NEURAL STIMULATION - Various aspects provide an implantable device. In various embodiments, the device comprises at least one port, where each port is adapted to connect a lead with an electrode to the device. The device further includes a stimulation platform, including a sensing circuit connected to the at least one port to sense an intrinsic cardiac signal and a stimulation circuit connected to the at least one port via a stimulation channel to deliver a stimulation signal through the stimulation channel to the electrode. The stimulation circuit is adapted to deliver stimulation signals through the stimulation channel for both neural stimulation therapy and CRM therapy. The sensing and stimulation circuits are adapted to perform CRM functions. The device further includes a controller connected to the sensing circuit and the stimulation circuit to control the neural stimulation therapy and the CRM therapy. Other aspects and embodiments are provided herein. | 05-06-2010 |
20100121393 | ISOLATION OF SENSING CIRCUIT FROM PACE GENERATOR - In a system for sensing electrical signals within a living body, and specifically for tracking location of an object in the body using impedance measurements, an isolation circuit maintains isolation between the pacing and position sensing circuits, even while the heart is being paced. | 05-13-2010 |
20100125306 | MASS ATTRIBUTE DETECTION THROUGH PHRENIC STIMULATION - According to certain examples, an implanted medical device is used to determine a mass attribute of a patient. The patient's phrenic nerve is stimulated, and the diaphragmatic response is measured by an accelerometer. The measured response is analyzed in certain embodiments to determine a mass attribute. This information can help in the diagnosis of, and efficient response to, edema. | 05-20-2010 |
20100145401 | MYOCARDIUM CONDITIONING USING MYOCARDIAL AND PARASYMPATHETIC STIMULATION - Various system embodiments comprise a neural stimulator, a pulse generator, and a controller. The neural stimulator is adapted to generate a neural stimulation signal. The pulse generator is adapted to generate a pacing signal to provide myocardium pacing. The controller is adapted to control the neural stimulator and the pulse generator to provide a cardioprotective conditioning therapy. The conditioning therapy includes neural stimulation to elicit a parasympathetic response and myocardium pacing. Other aspects and embodiments are provided herein. | 06-10-2010 |
20100152801 | Cardiac Resynchronization Therapy Optimization Using Vector Measurements Obtained from Realtime Electrode Position Tracking - An exemplary method includes selecting multiple electrodes located in a patient; acquiring position information during one or more cardiac cycles for the multiple electrodes where the acquiring includes using each of the electrodes for measuring one or more electrical potentials in an electrical localization field established in the patient; calculating one or more vector metrics based on the acquired position information for one or more vectors, each vector defined by two of the multiple electrodes; and analyzing the one or more vector metrics to assess cardiac performance during the one or more cardiac cycles. Various other methods, devices, systems, etc., are also disclosed. | 06-17-2010 |
20100160991 | IMPLANTABLE PULSE GENERATOR EMI FILTERED FEEDTHRU - Disclosed herein is an implantable pulse generator. The implantable pulse generator includes a header, a can and a feedthru. The header includes a lead connector block electrically coupled to a first conductor. The can is coupled to the header and includes a wall and an electronic component electrically connected to a second conductor and housed within the wall. The feedthru is mounted in the wall and includes an electrically insulating core, a PCB, a shield, a chip capacitor, a power circuit and a ground circuit. A first side of the PCB abuts against the core and a second side of the PCB abuts against an edge of the shield. The chip capacitor is mounted on the second side of the PCB. The chip capacitor is enclosed in a volume defined by an interior of the shield and the second side of the PCB. A first electrical contact of the chip capacitor is electrically coupled to the power circuit, which extends between the first and second conductors. A second electrical contact of the chip capacitor is electrically coupled to the ground circuit, which is electrically coupled to the wall. | 06-24-2010 |
20100179609 | METHOD FOR PREPARING AN IMPLANTABLE CONTROLLED GENE OR PROTEIN DELIVERY DEVICE - An implantable system which includes a gene/protein delivery device and a pulse generator, as well as method of preparing the gene/protein delivery device and using the system, are provided. In one embodiment, the implantable system detects a predetermined condition or event and, in response, delivers gene(s) and/or protein(s) in conjunction with delivering pacing and/or defibrillation pulses. | 07-15-2010 |
20100198288 | Leadless Cardiac Pacemaker with Secondary Fixation Capability - The invention relates to leadless cardiac pacemakers (LBS), and elements and methods by which they affix to the heart. The invention relates particularly to a secondary fixation of leadless pacemakers which also include a primary fixation. Secondary fixation elements for LBS's may passively engage structures within the heart. Some passive secondary fixation elements entangle or engage within intraventricular structure such as trabeculae carneae. Other passive secondary fixation elements may engage or snag heart structures at sites upstream from the chamber where the LBS is primarily affixed. Still other embodiments of passive secondary fixation elements may include expandable structures. | 08-05-2010 |
20100204743 | METHODS AND APPARATUS FOR REDUCING SPURIOUS SIGNALS IN IMPLANTABLE MEDICAL DEVICES CAUSED BY X-RAY RADIATION - An implantable medical device (IMD) includes a detector for detecting the presence of x-ray radiation, where the presence of x-ray radiation is detected in response to the strength of the x-ray radiation exceeding a first threshold. In one embodiment, the IMD includes a processor for adjusting a cardiac stimulation rate IMD in response to determining that the strength of the detected x-ray radiation exceeds a second threshold. The second pre-selected x-ray radiation threshold is greater than the first pre-selected x-ray radiation threshold. In another embodiment, the implantable device includes a detector for detecting the presence of any amount x-ray radiation and a processor for adjusting a stimulation rate provided by the IMD in response to detected x-ray radiation to reduce the chance of over-sampling artifacts or inappropriate therapy delivery. | 08-12-2010 |
20100234911 | METHOD AND APPARATUS FOR A CAPACITOR SHELL INCLUDING TWO MATEABLE CUPPED COMPONENTS - One embodiment of the present subject matter includes a capacitor, comprising a first metallic cupped shell having a first opening, and a second metallic cupped shell having a second opening, wherein the first opening and the second opening are adapted to sealably mate to form a closed shell defining a volume therein. In the embodiment, the closed shell is adapted for retaining electrolyte. A plurality of capacitor layers in a substantially flat arrangement are disposed within the volume, along with electrolyte, in the present embodiment. The present closed shell includes one or more ports for electrical connections. | 09-16-2010 |
20100241183 | APPARATUS FOR AUTONOMIC NEUROMODULATION FOR THE TREATMENT OF SYSTEMIC DISEASE - A method, apparatus, and surgical technique for the modulation of autonomic function, for the purpose of treating any of several conditions and diseases, including obesity, metabolic disorders, endocrine disorders, diabetes, respiratory disease, asthma, inflammatory disease, immunological disease, infection, cancer, cardiac disease, cardiovascular disease, cerebrovascular disease, stroke, vasospasm, vascular disease, psychiatric disease, depression, affective disorders, anxiety disorders, and other conditions. This includes neural and tissue modulators, including implanted devices, used to modulate efferent and afferent autonomic neurons to influence or control autonomic or other neural function, including modulation of sympathetic and parasympathetic nervous system components as well as their combination. | 09-23-2010 |
20100249861 | ELECTRONIC MODULE ASSEMBLY FOR FILTERED FEEDTHROUGHS - An electronic module assembly (EMA) for an implantable medical device is disclosed. The EMA comprises a non-conductive block having a top side, a bottom side, a front side and a back side. A plurality of conductive strips are coupled to the non-conductive block. Each conductive strip possesses a front side and a back side. The back side of each conductive strip extends from the front side across the top side and over to back side of the non-conductive block. | 09-30-2010 |
20100262203 | DETERMINATION OF SITE OF ORIGIN FOR A NATURAL ELECTRICAL PULSE IN A LIVING BODY - Techniques include determining a first vector of temporal changes in electrical data measured at multiple electrical sensors positioned at corresponding locations on a surface of a living body due to a natural electrical pulse. A different vector of temporal changes in electrical data measured at the same electrical sensors is determined due to each stimulated signal of multiple stimulated signals within the living body. Stimulated position data is received, which indicates a different corresponding position within the living body where each of the stimulated signals originates. The site of origin of the natural electrical pulse is determined based on the first vector and the multiple different vectors and the stimulated position data. Among other applications, these techniques allow the rapid, automatic determination of the site of origin of ventricular tachycardia arrhythmia (VT). | 10-14-2010 |
20100274308 | USE OF CARDIAC PARAMETERS IN METHODS AND SYSTEMS FOR TREATING A CHRONIC MEDICAL CONDITION - Disclosed herein are methods, systems, and apparatus for treating a chronic medical condition in a patient. A time of beat sequence of the patient's heart is determined. A regulatory system parameter is determined based on the time of beat sequence. The parameter is indicative of a stress level of the patient's regulatory adaptation systems. The determined regulatory system parameter is compared with a threshold regulatory system parameter value. An electrical signal is applied to a neural structure of the patient to treat the chronic medical condition if the determined regulatory system parameter exceeds the threshold regulatory system parameter value. | 10-28-2010 |
20100292749 | Sub-Xiphoid Ablation Clamp and Method of Sub-Xiphoid Ablation - Device and method for sub-xiphoid ablation of patient tissue. A sub-xiphoid access clamp has a handle, an elongate neck coupled to the handle and first and second opposing jaws. The first and second opposing jaws have first and second opposing relief segments being generally co-planar and concave with respect to one another to form a void therebetween, and first and second opposing elongate ablation elements positioned along the first and second opposing jaws and distal of the first and second opposing relief segments relative to the handle. The first and second opposing jaws are articulate between a closed position and an open position to admit, at least in part, a second portion of tissue of the patient within the void created by the first and second opposing relief segments while the first portion of tissue is positioned between the first and second ablation elements in the closed position. | 11-18-2010 |
20100298900 | CARDIAC PACEMAKER WITH TABLE-BASED PACING MODE IMPLEMENTATION - A device and method for implementing a bradycardia pacing mode are disclosed which is mostly hardware-based but still allows the flexibility for making major changes in brady behavior normally found only in firmware-based implementations. The brady behavior of the device is encapsulated by a table in an area of RAM referred to as brady RAM, and the brady behavior can be changed by re-loading the brady RAM with a different table. | 11-25-2010 |
20100305636 | ELONGATE BATTERY FOR IMPLANTABLE MEDICAL DEVICE - A battery assembly for a medical device includes an elongate cathode, an elongate anode, an electrolyte, and an elongate housing assembly encapsulating the cathode, the anode, and the electrolyte. The battery assembly also includes a first electrode that is exposed from and electrically insulated from the housing assembly. One of the anode and the cathode is electrically coupled to the first electrode, and the other of the anode and the cathode is electrically coupled to the housing assembly. One of the cathode and the anode includes a first portion and a second portion disposed in spaced relationship from the first portion. The other of the cathode and the anode is disposed between the first and second portions. | 12-02-2010 |
20100305637 | Respiration Sensor Processing for Phrenic Nerve Activation Detection - An implantable cardiac device includes a sensor for sensing patient respiration and detecting phrenic nerve activation. A first filter channel attenuates first frequencies of the sensor signal to produce a first filtered output. A second filter channel attenuates second frequencies of the respiration signal to produce a second filtered output. Patient activity is evaluated using the first filtered output and phrenic nerve activation caused by cardiac pacing is detected using the second filtered output. | 12-02-2010 |
20100312298 | SYSTEMS AND METHODS TO CONFIGURE A MULTI-ELECTRODE LEAD - Methods and systems are provided for configuring a Multi-Electrode Lead (MEL) that includes N groups of electrodes, with each of the N groups of electrodes including at least M electrodes, where N≧2 and M≧2. Sent via the MEL is a first communication sequence of bits that includes N groups of bits, with each of the N groups of bits corresponding to a different one of the N groups of electrodes and specifying which electrode(s), if any, within the group of electrodes is to be configured as an anode. Also sent via the MEL is a second communication sequence of bits that includes N further groups of bits, with each of the N further groups of bits corresponding to a different one of the N groups of electrodes and specifying which electrode(s), if any, within the group of electrodes is to be configured as a cathode. | 12-09-2010 |
20100324617 | ADAPTER FOR ELECTROSTIMULATION LEAD AND METHOD FOR REDUCING EXTRACARDIAC STIMULATION - A method of cardiac electrostimulation of a patient with a cardiac electrostimulation device includes implanting a first electrode in the left ventricle of the patient. A second electrode is implanted in the heart of the patient. In some embodiments, the first electrode and second electrode are electrically connected in parallel and share a common anode. The method reduces the likelihood of phrenic stimulation in the patient. Adapters and electrostimulation devices are also disclosed. | 12-23-2010 |
20100324618 | CONSTANT CURRENT PACING APPARATUS AND PACING METHOD - A constant current pacing apparatus and method for pacing uses, for example, H-bridge circuitry and a constant current source connected to the H-bridge circuitry. | 12-23-2010 |
20110071586 | Leadless Cardiac Pacemaker Triggered by Conductive Communication - A leadless cardiac pacemaker configured for implantation in electrical contact with a left ventricular cardiac chamber and configured for leadless triggered left-ventricular pacing for cardiac resynchronization therapy (CRT) in response to conducted signals from a pulse generator. | 03-24-2011 |
20110077702 | Means and Methods for Influencing Electrical Activity of Cells - The invention provides means and methods for providing a cell with a spontaneous electrical activity and means and methods for increasing the depolarization rate of a cell having a spontaneous electrical activity. Means and methods are provided comprising: | 03-31-2011 |
20110087302 | MRI COMPATIBLE MEDICAL DEVICE LEAD INCLUDING TRANSMISSION LINE NOTCH FILTERS - A medical device lead includes a conductor and one or more band stop filters. The conductor extends through a lead body and includes a proximal end and a distal end. The one or more band stop filters each have a first end and a second end and include a conductive coil. At least one of the first end and second end of each band stop filter is coupled to the conductor. A length of each band stop filter is such that, at magnetic resonance imaging (MRI) frequencies, the band stop filter phase shifts an MRI-induced signal on the conductor by 180° to attenuate the MRI-induced signal on the conductor. | 04-14-2011 |
20110093027 | Active Implantable Medical Device For Cardiac Resynchronization With Automatic Optimization Of Atrioventricular And Interventricular Delays - An active implantable medical device for cardiac resynchronization with automatic optimization of atrioventricular and interventricular delays is disclosed. The device collects an endocardial acceleration signal EA and calculates the atrioventricular delay AVD and the interventricular delay VVD. The device isolate in the EA signal a component EA4 corresponding to the fourth EA peak and measure a temporal parameter related to a time interval between the detection of an atrial event (P/A) and the occurrence of the EA4 component. The device isolates an EA1 component corresponding to the first EA peak and measures a non-temporal parameter (A | 04-21-2011 |
20110093028 | APPARATUS AND METHOD FOR DELIVERING ELECTRICAL SIGNALS TO MODIFY GENE EXPRESSION IN CARDIAC TISSUE - The description above should not be construed as limiting the scope of the invention to the specific embodiments described, which are provided merely as examples or illustrations. The scope of the invention encompasses interchangeable substitutions that are known to or would be appreciated by those skilled in the art. Many other variations are possible. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents, rather than by only the examples given above. | 04-21-2011 |
20110118801 | NERVE STIMULATION DEVICE - To provide a nerve stimulation device capable of stimulating a vagus nerve stably while reducing the risk of interrupting a treatment by nerve stimulation due to disconnection or the like. Adopted is a nerve stimulation device including a first electrode and a second electrode disposed in different positions on the vagus nerve, a pulse generating part connected to each of these electrodes, for outputting an electric pulse for stimulating the vagus nerve, and a setting part for switching the electrode to which the electric pulse from the pulse generating part is transmitted. | 05-19-2011 |
20110152960 | SINTERED CAPACITOR ELECTRODE INCLUDING MULTIPLE THICKNESSES - An example includes a capacitor case sealed to retain electrolyte, at least one anode disposed in the capacitor case, the at least one anode comprising a sintered portion disposed on a substrate, an anode conductor coupled to the substrate in electrical communication with the sintered portion, the anode conductor sealingly extending through the capacitor case to an anode terminal disposed on the exterior of the capacitor case with the anode terminal in electrical communication with the sintered portion, a cathode disposed in the capacitor case, a separator disposed between the cathode and the anode and a cathode terminal disposed on an exterior of the capacitor case and in electrical communication with the cathode, with the anode terminal and the cathode terminal electrically isolated from one another. | 06-23-2011 |
20110152961 | ELECTRIC ENERGY STORAGE DEVICE ELECTRODE INCLUDING AN OVERCURRENT PROTECTOR - One embodiment includes a capacitor case sealed to retain electrolyte, at least one electrode disposed in the capacitor case, the at least one electrode comprising an overcurrent protector, a conductor coupled to the overcurrent protector and in electrical communication with a remainder of the electrode, the conductor sealingly extending through the capacitor case to a terminal disposed on an exterior of the capacitor case, a second electrode disposed in the capacitor case, a separator disposed between the electrode and the second electrode and a second terminal disposed on the exterior of the capacitor case and in electrical communication with the second electrode, with the terminal and the second terminal electrically isolated from one another, wherein the overcurrent protector is to interrupt electrical communication between the terminal and the remainder of the electrode at a selected current level. | 06-23-2011 |
20110224749 | NERVE STIMULATION TECHNIQUES - A method is provided for treating heart failure in a subject in need of such treatment, including applying a stimulating current to parasympathetic nervous tissue of the subject, selected from the group consisting of: a vagus nerve and an epicardial fat pad. The stimulating current is configured to inhibit release of at least one proinflammatory cytokine sufficiently to the treat heart failure of the subject. A level of the at least one proinflammatory cytokine is measured. Optionally, the stimulating current is configured to change a level of Connexin 43 of the subject, and the level of Connexin 43 is also measured. Other embodiments are also described. | 09-15-2011 |
20110264158 | HIS-BUNDLE CAPTURE VERIFICATION AND MONITORING - This document discusses, among other things, a system and method for generating a stimulation energy to provide His-bundle stimulation for a cardiac cycle, receiving electrical information from the heart over at least a portion of the cardiac cycle, determining a characteristic of at least a portion of the received electrical information for the cardiac cycle, and classifying the cardiac cycle using the determined characteristic. | 10-27-2011 |
20110270339 | Two-Stage Delivery Systems and Methods for Fixing a Leadless Implant to Tissue - Systems and methods of delivering and retaining a leadless medical implant to tissue, wherein a docking base and the implant are sequentially delivered to an implantation site. In a first stage, the docking base is delivered and deployed into tissue at an implantation site. In a second stage, the implant is navigated through the vasculature and coupled to the docking base. Various mechanisms for navigating the implant to the previously implanted docking base and coupling the implant thereto are described. Navigational mechanisms include advancing the implant over a proximally extending wire portion that is releasably attached to the previously implanted docking base, utilizing fluoroscopic visualization to guide the implant to a previously implanted docking base that is at least partially radiopaque and utilizing electromagnetism to guide the implant to a previously implanted docking base that is electro-magnetizable. | 11-03-2011 |
20110270340 | Two-Stage Delivery Systems and Methods for Fixing a Leadless Implant to Tissue - Systems and methods of delivering and retaining a leadless medical implant to tissue, wherein a docking base and the implant are sequentially delivered to an implantation site. In a first stage, the docking base is delivered and deployed into tissue at an implantation site. In a second stage, the implant is navigated through the vasculature and coupled to the docking base. Various mechanisms for navigating the implant to the previously implanted docking base and coupling the implant thereto are described. Navigational mechanisms include advancing the implant over a proximally extending wire portion that is releasably attached to the previously implanted docking base, utilizing fluoroscopic visualization to guide the implant to a previously implanted docking base that is at least partially radiopaque and utilizing electromagnetism to guide the implant to a previously implanted docking base that is electro-magnetizable. | 11-03-2011 |
20110270341 | HERMETIC WAFER-TO-WAFER BONDING WITH ELECTRICAL INTERCONNECTION - An implantable medical device (IMD) is disclosed. The IMD includes a first substrate having a front side and a backside. A first via is formed in the front side, the via extending from a bottom point in the front side to a first height located at a surface of the front side. A first conductive pad is formed in the first via, the first conductive pad having an exposed top surface lower than first height. A second substrate is coupled to the first substrate, the second substrate having a second via formed in the front side, the via extending from a bottom point in the front side to a second height located at a surface of the front side. A second conductive pad is formed in the second via, the second conductive pad having an exposed top surface lower than second height. The coupled substrates are heated until a portion of one or both conductive pads reflow, dewet, agglomerate, and merge to form an interconnect, hermetic seal, or both depending on the requirements of the device. | 11-03-2011 |
20110276103 | OUTPUT CIRCUIT FOR BOTH CARDIAC CONTRACTILE ELECTROSTIMULATION AND NON-CONTRACTILE NEURAL MODULATION - An apparatus comprises an electrostimulation energy storage capacitor, a circuit path that provides pacing stimulation from the capacitor through the load, a constant current neural stimulation circuit that is switchable into the circuit path to provide neural stimulation through the load and switchable out of the circuit path to provide the pacing stimulation through the load, and a control circuit configured to selectively enable delivery of the pacing stimulation or the constant current neural stimulation. | 11-10-2011 |
20110301658 | SPATIALLY SELECTIVE VAGUS NERVE STIMULATION - By targeting on selected branches or fascicles of a vagus nerve using electrode placement and/or selection, one or more target branches of the vagus nerve are substantially activated by electrical stimulation pulses delivered to a branch without substantially activating one or more non-target branches. In one embodiment, vagus nerve stimulation is delivered through an electrode placed on a thoracic vagus nerve that is separated from a recurrent laryngeal nerve, such that the vagus nerve is stimulated without causing laryngeal muscle contractions. In another embodiment, vagus nerve stimulation is delivered through a multi-contact electrode with one or more contacts selected for delivering the electrical stimulation pulses to stimulate the vagus nerve without causing laryngeal muscle contractions. | 12-08-2011 |
20110301659 | VAGUS NERVE STIMULATION WITH TARGET EFFECTS CONTROLLED BY ADJUSTING TEMPORAL PARAMETERS - One or more temporal stimulation parameters of vagus nerve stimulation (VNS) are selected to substantially modulate one or more target physiological functions without substantially modulating one or more non-target physiological functions. In one embodiment, a stimulation duty cycle is selected such that VNS is delivered to the cervical vagus nerve trunk to modulate a cardiovascular function without causing laryngeal muscle contractions. | 12-08-2011 |
20120010674 | CONTROLLED DELIVERY OF INTERMITTENT STRESS AUGMENTATION PACING FOR CARDIOPROTECTIVE EFFECT - A device and method for delivering electrical stimulation to the heart in a manner which provides a protective effect against subsequent ischemia is disclosed. The protective effect is produced by configuring a cardiac pacing device to intermittently switch from a normal operating mode to a stress augmentation mode in which the spatial pattern of depolarization is varied to thereby subject a particular region or regions of the ventricular myocardium to increased mechanical stress. | 01-12-2012 |
20120041501 | IMPLANTABLE MEDICAL DEVICE WITH ADAPTIVE OPERATION - An implantable medical device operates with an algorithm that promotes intrinsic conduction and reduces ventricular pacing. The IMD monitors the occurrence of necessary ventricular pacing and takes certain actions based upon whether this occurrence has been relatively high or relatively low. When noise is detected, asynchronous pacing is provided when the occurrence is relatively high and is not provided when relatively low. When atrial threshold testing is performed, the incidence will determine which methodology is utilized. | 02-16-2012 |
20120041502 | Cardiac Stimulation Apparatus And Method For The Control Of Hypertension - A method that electrically stimulates a heart muscle to alter the ejection profile of the heart, to control the mechanical function of the heart and reduce the observed blood pressure of the patient. The therapy may be invoked by an implantable blood pressure sensor associated with a pacemaker like device. In some cases, where a measured pretreatment blood pressure exceeds a treatment threshold, a patient's heart may be stimulated with an electrical stimulus timed relative to the patient's cardiac ejection cycle. This is done to cause dyssynchrony between at least two cardiac chambers or within a cardiac chamber, which alters the patient's cardiac ejection profile from a pretreatment cardiac ejection profile. This has the effect of reducing the patient's blood pressure from the measured pretreatment blood pressure. | 02-16-2012 |
20120071941 | SELECTIVELY CONNECTING THE TIP ELECTRODE DURING THERAPY FOR MRI SHIELDING - A medical device includes a pulse generator and an electrode configured to contact tissue in a body vessel. The medical device includes a lead that includes a lead connector. The lead connector connects a pulse generator with an electrode via a conductive path. An electrode switch is electrically connected between the lead conductor and the electrode. The electrode switch includes an open state preventing the conductive path between the lead and the electrode. The electrode switch includes a closed state establishing the conductive path between the lead and the electrode when a voltage is applied across the electrode switch that exceeds a threshold voltage. The electrode switch in the open state electrically shields the electrode from electromagnetic radiation and induced voltages during magnetic resonance imaging. | 03-22-2012 |
20120078319 | STIMULATION DESIGN FOR NEUROMODULATION - The present application relates to a new stimulation design which can be utilized to treat neurological conditions. The stimulation system produces a burst mode stimulation which alters the neuronal activity of the predetermined site, thereby treating the neurological condition or disorder. The burst stimulus comprises a plurality of groups of spike pulses having a maximum inter-spike interval of 100 milliseconds. The burst stimulus is separated by a substantially quiescent period of time between the plurality of groups of spike pulses. This inter-group interval may comprise a minimum of 5 seconds. | 03-29-2012 |
20120101540 | WAFER-SCALE PACKAGE INCLUDING POWER SOURCE - A medical device includes a first substrate, a second substrate, a control module, and an energy storage device. The first substrate includes at least one of a first semiconductor material and a first insulating material. The second substrate includes at least one of a second semiconductor material and a second insulating material. The second substrate is bonded to the first substrate such that the first and second substrates define an enclosed cavity between the first and second substrates. The control module is disposed within the enclosed cavity. The control module is configured to at least one of determine a physiological parameter of a patient and deliver electrical stimulation to the patient. The energy storage device is disposed within the cavity and is configured to supply power to the control module. | 04-26-2012 |
20120109241 | Enhancement of Biological Functioning by the use of Electromagnetic and Magnetic Fields - Systems and methods are provided for treating a living being with multiple, concurrent, superimposed non-phase-locked signals, at physiologically acceptable intensities and duty cycles such that the signals entrain the tissue. Preferred signals are electromagnetic, and at least one of the frequencies is selected from the list consisting of 7.6 Hz +/−2 Hz. 70.25 Hz+/−0.25 Hz, 71.25 Hz+/−0.25 Hz, and 3040 Hz +/−10 Hz. Among other things, it is contemplated that the signals can be used to create a subjective reduction in pain, mood improvement, to treat osteoporosis, to enhance cardiac function, and/or affect the hypothalamic pituitary axis. | 05-03-2012 |
20120158078 | IMPLANTABLE MEDICAL DEVICE VOLTAGE DIVIDER CIRCUIT FOR MITIGATING ELECTROMAGNETIC INTERFERENCE - An RF protection circuit mitigates potentially adverse effects that may otherwise result from electromagnetic interference (e.g., due to MRI scanning of a patient having an implanted medical device). The RF protection circuit may comprise a voltage divider that is deployed across a pair of cardiac electrodes that are coupled to internal circuitry of the implantable medical device. Each leg of the voltage divider may be referenced to a ground of the internal circuit, whereby the different legs are deployed in parallel across different circuits of the internal circuitry. In this way, when an EMI-induced (e.g., MRI-induced) signal appears across the cardiac electrodes, the voltages appearing across these circuits and the currents flowing through these circuits may be reduced. The RF protection circuit may be used in an implantable medical device that employs a relatively low capacitance feedthrough to reduce EMI-induced (e.g., MRI-induced) current flow in a cardiac lead. | 06-21-2012 |
20120158079 | SYSTEMS AND METHODS FOR ASSESSING THE SPHERICITY AND DIMENSIONAL EXTENT OF HEART CHAMBERS FOR USE WITH AN IMPLANTABLE MEDICAL DEVICE - Techniques are provided for use with an implantable medical device for assessing left ventricular (LV) sphericity and atrial dimensional extent based on impedance measurements for the purposes of detecting and tracking heart failure and related conditions such as volume overload or mitral regurgitation. In some examples described herein, various short-axis and long-axis impedance vectors are exploited that pass through portions of the LV for the purposes of assessing LV sphericity. In other examples, impedance measurements taken along a vector between a right atrial (RA) ring electrode and an LV electrode implanted near the atrioventricular (AV) groove are exploited to assess LA extent, biatrial extent or mitral annular diameter. The assessment techniques can be employed alone or in conjunction with other heart failure detection techniques, such as those based on left atrial pressure (LAP.) | 06-21-2012 |
20120158080 | MRI-COMPATIBLE IMPLANTABLE DEVICE - A medical device containing a device for connecting the medical device to a substrate, for furnishing electrical impulses from the medical device to the substrate, for ceasing the furnishing of electrical impulses to the substrate, for receiving pulsed radio frequency fields, for transmitting and receiving optical signals, and for protecting the substrate and the medical device from currents induced by the pulsed radio frequency fields. The medical device contains a control circuit comprised of a parallel resonant frequency circuit. | 06-21-2012 |
20120165886 | ELECTRICAL STIMULATION DEVICE FOR TREATING CARDIOVASCULAR DISEASE AND METHOD FOR TREATING CARDIOVASCULAR DISEASE - The object of the invention is to provide a new treatment method and treatment device that together with being able to improve a drop in cardiac contractility when treating cardiovascular disease such as acute myocardial infarction and suppress the occurrence of arrhythmia, is able to reduce the infarct size. Provided is an electrical stimulation device for treating cardiovascular disease having at least one electrode that is placed on a nerve site in the body of an animal, and an electrical stimulation application unit that applies electrical stimulation by the electrode to the vagus nerve in the neck region of the animal; and a method for treating cardiovascular disease in an animal having a step of placing an electrode in contact with the vagus nerve in the neck region of an animal, and a step of applying electrical stimulation to the animal. | 06-28-2012 |
20120215272 | Methods and Apparatus to Increase Secretion of Endogenous Naturetic Hormones - A method and apparatus for treatment of heart failure by increasing secretion of endogenous naturetic hormones ANP and BNP such as by stimulation of the heart atria. Heart pacing is done at an atrial contraction rate that is increased and can be higher than the ventricular contraction rate. Pacing may include mechanical distension of the right atrial appendage. An implantable device is used to periodically cyclically stretch the walls of the appendage with an implanted balloon. | 08-23-2012 |
20120239100 | ATRIAL NERVE STIMULATION WITH VENTRICULAR PACING - A method and medical device for delivering an atrial pacing pulse to an atrial chamber to generate an evoked atrial depolarization, delivering a stimulation pulse to an atrioventricular node during a stimulation window to increase a PR interval of the heart, the stimulation window having a start time corresponding to the delivered atrial pacing pulse so that the stimulation pulse is delivered during a refractory period corresponding to the evoked atrial depolarization, and delivering a ventricular pacing pulse to a first ventricular chamber during the increased PR interval to cause a contraction of the first ventricular chamber to occur prior to a contraction of a second ventricular chamber to increase dyssynchrony between the contraction of the first ventricular chamber and the contraction of the second ventricular chamber. | 09-20-2012 |
20120245649 | SYSTEM AND METHOD FOR CONTACTLESS POWER TRANSFER IN IMPLANTABLE DEVICES - A system and method for contactless power transfer in implantable devices for charging rechargeable batteries disposed within the implantable devices are provided. The system includes a first coil electrically couplable to a power source, wherein the first coil is configured to produce a magnetic field. The system further includes a second coil electrically coupled to the rechargeable battery disposed within the implantable device and configured to receive power from the first coil via the magnetic field and to transfer the power to the rechargeable battery. The system also includes a field focusing element disposed between the first coil and the second coil and configured as a self resonant coil having a standing wave current distribution to focus the magnetic field onto the second coil and enhance the coupling between the first coil and the second coil. | 09-27-2012 |
20130103107 | LEAD WIRE AND PACEMAKER USING THE SAME - A lead wire and a pacemaker using the lead wire are disclosed. The lead wire, comprising: a lead body and a lead electrode at an end of the lead body, the lead electrode being electrically connected with the lead body, the lead electrode comprising a carbon nanotube structure, the carbon nanotube structure comprising at least one carbon nanotube film, the carbon nanotube structure having an electrode tip away from the lead body, and the electrode tip being in linear contact with an organ, wherein the electrode tip functions as a stimulating electrode, the at least one carbon nanotube film acts as a sensing electrode. | 04-25-2013 |
20130116739 | METHOD AND SYSTEM FOR DETECTING AND ANALYZING HEART MECAHNICS - Method and apparatus for detecting and analyzing heart mechanical activity at a region of interest of a patient's heart are provided. The method comprises acquiring a time sequence of 2-dimensional X-ray images of a region of interest over at least part of a cardiac cycle; detecting coronary vessels in the X-ray images; tracking the coronary vessels through the sequence of images to identify movements of the coronary vessels; and analyzing the movements of the coronary vessels to quantify at least one parameter characterizing heart wall motion in the region of interest. | 05-09-2013 |
20130116740 | SINGLE-CHAMBER LEADLESS INTRA-CARDIAC MEDICAL DEVICE WITH DUAL-CHAMBER FUNCTIONALITY AND SHAPED STABILIZATION INTRA-CARDIAC EXTENSION - A leadless intra-cardiac medical device (LIMD) configured to be implanted entirely within a heart of a patient includes a housing configured to be securely attached to an interior wall portion of a chamber of the heart, and a stabilizing intra-cardiac (IC) device extension connected to the housing. The stabilizing IC device extension may include a stabilizer arm, and/or an appendage arm, or an elongated body or a loop member configured to be passively secured within the heart. | 05-09-2013 |
20130116741 | DUAL-CHAMBER LEADLESS INTRA-CARDIAC MEDICAL DEVICE WITH INTRA-CARDIAC EXTENSION - A leadless intra-cardiac medical device includes a housing that is configured to be implanted entirely within a single local chamber of the heart. A first electrode is provided on the housing at a first position such that when the housing is implanted in the local chamber, the first electrode engages the local wall tissue at a local activation site within the conduction network of the local chamber. An intra-cardiac extension is coupled to the housing and configured to extend from the local chamber into an adjacent chamber of the heart. A stabilization arm of the intra-cardiac extension engages the adjacent chamber. A second electrode on the intra-cardiac extension engages distal wall tissue at a distal activation site within the conduction network of the adjacent chamber. | 05-09-2013 |
20130131745 | ELECTROCHEMICAL CELL WITH ADJACENT CATHODES - The disclosure includes an electrochemical cell comprising a first cathode and a second cathodes are adjacent one another in a stacked arrangement to form a cathode stack in the electrochemical cell. The first cathode includes a first current collector and a first cathode form of active material covering the first current collector, and the second cathode includes a second current collector and a second cathode form of active material covering the second current collector. The second current collector is in electrical contact with the first current collector. The electrochemical cell further comprises an anode adjacent to the cathode stack, and a separator located between the cathode stack and the anode. | 05-23-2013 |
20130131746 | NON-INVASIVE VAGUS NERVE STIMULATION DEVICES AND METHODS TO TREAT OR AVERT ATRIAL FIBRILLATION - Energy is transmitted noninvasively to a patient using electrode-based stimulation devices or magnetic stimulation devices that are designed to non-invasively stimulate nerves selectively. The devices produce impulses that are used to treat atrial fibrillation, by stimulating a vagus nerve of a patient. The devices are also used to forecast the imminent onset of atrial fibrillation and then avert it by stimulating a vagus nerve. | 05-23-2013 |
20130184773 | Vagus Nerve Neurostimulator With Multiple Patient-Selectable Modes For Treating Chronic Cardiac Dysfunction - A vagus nerve neurostimulator system with multiple patient-selectable modes for treating chronic cardiac dysfunction is provided. An implantable neurostimulator includes a pulse generator coupled to a therapy lead terminated by a pair of helical electrodes positioned over a cervical vagus nerve. The pulse generator is configured to deliver through the helical electrodes continuously-cycling, intermittent and periodic electrical stimulation that is parametrically defined to bi-directionally propagate through nerve fibers in the cervical vagus nerve. The implantable neurostimulator includes a magnetic switch configured to switch the pulse generator between a plurality of operating modes that are each separately selectable in response to a unique and remotely-applied magnetic signal. An external controller includes patient-actuatable controls configured to enable selection of one of the operating modes of the pulse generator. The external controller includes an electromagnetic transmitter configured to output the magnetic signal uniquely associated with the operating mode as selected with the controls. | 07-18-2013 |
20130296958 | COMBINED REMODELING CONTROL THERAPY AND ANTI-REMODELING THERAPY BY IMPLANTABLE CARDIAC DEVICE - A method and device for delivering ventricular resynchronization pacing therapy in conjunction with electrical stimulation of nerves which alter the activity of the autonomic nervous system is disclosed. Such therapies may be delivered by an implantable device and are useful in preventing the deleterious ventricular remodeling which occurs as a result of a heart attack or heart failure. The device may perform an assessment of cardiac function in order to individually modulate the delivery of the two types of therapy. | 11-07-2013 |
20140039570 | BIOSTIMULATOR CIRCUIT WITH FLYING CELL - A leadless cardiac pacemaker is provided which can include any number of features. In one embodiment, the pacemaker can include a tip electrode, pacing electronics disposed on a p-type substrate in an electronics housing, the pacing electronics being electrically connected to the tip electrode, an energy source disposed in a cell housing, the energy source comprising a negative terminal electrically connected to the cell housing and a positive terminal electrically connected to the pacing electronics, wherein the pacing electronics are configured to drive the tip electrode negative with respect to the cell housing during a stimulation pulse. The pacemaker advantageously allows p-type pacing electronics to drive a tip electrode negative with respect to the can electrode when the can electrode is directly connected to a negative terminal of the cell. Methods of use are also provided. | 02-06-2014 |
20140052207 | THERAPY DELIVERY ARCHITECTURE FOR IMPLANTABLE MEDICAL DEVICE - An implantable medical device (IMD) may include multiple power supply circuits and an electrostimulation therapy output circuit configured to, in response to a control signal specifying an electrostimulation therapy, controllably connect any one or more of the first or second power supply circuits to any one or more of a first electrostimulation output node or a second electrostimulation output node to deliver an electrostimulation. In an embodiment, the IMD may include an electrostimulation therapy return circuit configured to establish a return path for the electrostimulation delivered via one or more of the first electrostimulation output node or the second electrostimulation output node. | 02-20-2014 |
20140107719 | SYSTEMS AND METHODS FOR POSTEXTRASYSTOLIC POTENTIATION USING ANODIC AND CATHODIC PULSES GENERATED BY AN IMPLANTABLE MEDICAL DEVICE - Techniques are provided for use with implantable medical devices to deliver paired or coupled postextrasystolic potentiation (PESP) pacing using split or bifurcated anodic and cathodic pulses. In a paired pacing example, a single-phase anodic pulse is delivered by the device that has sufficient amplitude to depolarize and contract myocardial tissue. During or just following a subsequent relative refractory period, a single-phase cathodic stimulation pulse is delivered that has sufficient amplitude to depolarize but not contract myocardial tissue, i.e., the cathodic pulse provides for PESP. In a coupled pacing example, the single-phase anodic pulse is delivered during or just following the relative refractory period of a first cardiac cycle; whereas the single-phase cathodic pulse is delivered during or immediately following the relative refractory period of the next consecutive cardiac cycle. | 04-17-2014 |
20140107720 | SYSTEMS AND METHODS FOR PACKED PACING USING BIFURCATED PACING PULSES OF OPPOSING POLARITY GENERATED BY AN IMPLANTABLE MEDICAL DEVICE - Techniques are provided for use with implantable medical devices to deliver packed pacing using split or bifurcated pulses of opposing polarity in different cardiac cycles. In one example, packed single-phase pulses are delivered by the device during a first cardiac cycle that serve to stimulate heart tissue. During the next cardiac cycle, packed single-phase stimulation pulse of opposing polarity are delivered that serve to recharge the pacing capacitors and also serve to stimulate heart tissue. By separating the pulses into separate cardiac cycles, near simultaneous multisite packed stimulation can be achieved within each cardiac cycle while providing for charge balancing and without interfering with sensing. Non-packed pacing with bifurcated pulses is also described. | 04-17-2014 |
20140214108 | IMPLANTABLE MEDICAL DEVICE VOLTAGE DIVIDER CIRCUIT FOR MITIGATING ELECTROMAGNETIC INTERFERENCE - An RF protection circuit mitigates potentially adverse effects that may otherwise result from electromagnetic interference (e.g., due to MRI scanning of a patient having an implanted medical device). The RF protection circuit may comprise a voltage divider that is deployed across a pair of cardiac electrodes that are coupled to internal circuitry of the implantable medical device. Each leg of the voltage divider may be referenced to a ground of the internal circuit, whereby the different legs are deployed in parallel across different circuits of the internal circuitry. In this way, when an EMI-induced (e.g., MRI-induced) signal appears across the cardiac electrodes, the voltages appearing across these circuits and the currents flowing through these circuits may be reduced. The RF protection circuit may be used in an implantable medical device that employs a relatively low capacitance feedthrough to reduce EMI-induced (e.g., MRI-induced) current flow in a cardiac lead. | 07-31-2014 |
20140336718 | ADAPTIVE MEDIUM VOLTAGE THERAPY FOR CARDIAC ARRHYTHMIAS - Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (MVT) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of MVT parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of MVT. Administration of MVT is automatically and dynamically adjusted to achieve specific treatment or life-support objectives, such as prolongation of the body's ability to endure and respond to MVT, specifically addressing the type of arrhythmia or other pathologic state of the patient with targeted treatment, a tiered-intensity MVT treatment strategy, and supporting patients in non life-critical conditions where the heart may nevertheless benefit from a certain level of assistance. | 11-13-2014 |
20140350622 | Microperfusive Electrical Stimulation - A method of treating a patient in cardiac arrest (e.g., in fibrillation, electrochemical dissociation, or asystole), the method comprising delivering an agent for enhancement of cardiac function to the coronary arteries of the patient; and microperfusing the patient's cardiac tissue by electromagnetically stimulating the cardiac issue at an energy level below a threshold sufficient to defibrillate the heart. | 11-27-2014 |
20150134022 | Cell electric stimulator with separate electrodes for electrical field shaping and for stimulation - An electric stimulator for heart, brain, organs and general cells with a possibly random shape and position of electrodes which enhances its performance for breaking the symmetry. Two types of electrodes are introduced: type-1, or active electrodes are similar to prior art, while type-2, or passive electrodes have not been used in this context. Passive electrodes are electrically insulated, being unable to inject current in the surrounding medium, but they are capable of shaping the electric field, which has consequence on the path of the stimulating currents injected by type-1 electrodes. The invention also discloses a supercapacitor-type passive electrode of type-2, which maximizes the stored charge on the electrode—therefore increasing the electric field magnitude created by it. | 05-14-2015 |
20150343210 | VENTRICULAR PACING TO AUGMENT ATRIAL NATRIURETIC HORMONE PRODUCTION - Intermittent delivery of ventricular pacing pulses synchronized to occur during an atrial diastole time period can be used to provide atrial stretch therapy and augment the production and release of atrial natriuretic hormone. | 12-03-2015 |
20150343216 | MODULATION OF ION CHANNELS - Electrical or magnetic fields oscillating at specific frequencies can modulate functions of ion channels in excitable cells. For example, an alternating current (AC) at a frequency that resonates with a particular type of ion channel can be applied to modulate conductance of the channel. | 12-03-2015 |
20160067498 | DETERMINING ONSETS AND OFFSETS OF CARDIAC DEPOLARIZATION AND REPOLARIZATION WAVES - An exemplary computer-implemented method is disclosed for detection of onset of depolarization on far-field electrograms (EGMs) or electrocardiogram (ECG)-or ECG-like signals. The method includes determining a baseline rhythm using a plurality of body-surface electrodes. The baseline rhythm includes an atrial marker and a ventricular marker. A pre-specified window is defined as being between the atrial marker and the ventricular marker. A low pass filter is applied to a signal within the window. A rectified slope of the signal within the window is determined. A determination is made as to whether a time point (t | 03-10-2016 |
20160082259 | CLOSED LOOP NEURAL STIMULATION SYNCHRONIZED TO CARDIAC CYCLES - Various aspects of the present subject matter relate to a method. According to various method embodiments, cardiac activity is detected, and neural stimulation is synchronized with a reference event in the detected cardiac activity. Neural stimulation is titrated based on a detected response to the neural stimulation. Other aspects and embodiments are provided herein. | 03-24-2016 |
20160158556 | ELECTROCHEMICAL CELL WITH ADJACENT CATHODES - The disclosure includes an electrochemical cell comprising a first cathode and a second cathodes are adjacent one another in a stacked arrangement to form a cathode stack in the electrochemical cell. The first cathode includes a first current collector and a first cathode form of active material covering the first current collector, and the second cathode includes a second current collector and a second cathode form of active material covering the second current collector. The second current collector is in electrical contact with the first current collector. The electrochemical cell further comprises an anode adjacent to the cathode stack, and a separator located between the cathode stack and the anode. | 06-09-2016 |
20160250481 | MAGNETIC FIELD SENSOR ARRANGEMENT | 09-01-2016 |
20180021567 | METHOD AND SYSTEM FOR DETERMINING PACE TIMING IN A LEADLESS CARDIAC PACEMAKER SYSTEM | 01-25-2018 |